- Home
- ETJ vs CRMD Comparison
ETJ vs CRMD Comparison
Compare ETJ & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETJ
- CRMD
- Stock Information
- Founded
- ETJ 2007
- CRMD 2006
- Country
- ETJ United States
- CRMD United States
- Employees
- ETJ N/A
- CRMD N/A
- Industry
- ETJ Finance Companies
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- ETJ Finance
- CRMD Health Care
- Exchange
- ETJ Nasdaq
- CRMD Nasdaq
- Market Cap
- ETJ 578.8M
- CRMD 877.5M
- IPO Year
- ETJ N/A
- CRMD 2010
- Fundamental
- Price
- ETJ $8.98
- CRMD $11.28
- Analyst Decision
- ETJ
- CRMD Strong Buy
- Analyst Count
- ETJ 0
- CRMD 7
- Target Price
- ETJ N/A
- CRMD $17.33
- AVG Volume (30 Days)
- ETJ 175.6K
- CRMD 2.2M
- Earning Date
- ETJ 01-01-0001
- CRMD 08-13-2025
- Dividend Yield
- ETJ 8.30%
- CRMD N/A
- EPS Growth
- ETJ N/A
- CRMD N/A
- EPS
- ETJ N/A
- CRMD 0.28
- Revenue
- ETJ N/A
- CRMD $82,553,827.00
- Revenue This Year
- ETJ N/A
- CRMD $238.38
- Revenue Next Year
- ETJ N/A
- CRMD $53.52
- P/E Ratio
- ETJ N/A
- CRMD $40.46
- Revenue Growth
- ETJ N/A
- CRMD N/A
- 52 Week Low
- ETJ $7.20
- CRMD $3.61
- 52 Week High
- ETJ $8.47
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- ETJ 56.41
- CRMD 39.54
- Support Level
- ETJ $8.60
- CRMD $11.13
- Resistance Level
- ETJ $9.09
- CRMD $11.86
- Average True Range (ATR)
- ETJ 0.08
- CRMD 0.65
- MACD
- ETJ 0.00
- CRMD -0.34
- Stochastic Oscillator
- ETJ 77.31
- CRMD 3.81
About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.